BR112018006787A2 - composições e métodos que compreendem o uso de enzimas alfa-glucanotransferase de exiguobacterium acetylicum e bacillus coagluans - Google Patents

composições e métodos que compreendem o uso de enzimas alfa-glucanotransferase de exiguobacterium acetylicum e bacillus coagluans

Info

Publication number
BR112018006787A2
BR112018006787A2 BR112018006787A BR112018006787A BR112018006787A2 BR 112018006787 A2 BR112018006787 A2 BR 112018006787A2 BR 112018006787 A BR112018006787 A BR 112018006787A BR 112018006787 A BR112018006787 A BR 112018006787A BR 112018006787 A2 BR112018006787 A2 BR 112018006787A2
Authority
BR
Brazil
Prior art keywords
alpha
glucanotransferase
compositions
methods
coagluans
Prior art date
Application number
BR112018006787A
Other languages
English (en)
Inventor
Kralj Slavko
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of BR112018006787A2 publication Critical patent/BR112018006787A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C12N9/1074—Cyclomaltodextrin glucanotransferase (2.4.1.19)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01025—4-Alpha-glucanotransferase (2.4.1.25)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

trata-se de uma alfa-glucanotransferase isolada e/ou purificada de exiguobacterium acetylicum, variantes geneticamente modificadas de modo recombinante da mesma, fragmentos ativos da mesma, ácidos nucleicos sintéticos que codificam a alfa-glucanotransferase e variantes da mesma, células hospedeiras que compreendem os ácidos nucleicos sintéticos e composições que compreendem a alfa-glucanotransferase. métodos de uso das composições incluem a fabricação de oligossacarídeos.
BR112018006787A 2015-10-06 2016-10-06 composições e métodos que compreendem o uso de enzimas alfa-glucanotransferase de exiguobacterium acetylicum e bacillus coagluans BR112018006787A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562238054P 2015-10-06 2015-10-06
PCT/US2016/055849 WO2017062687A1 (en) 2015-10-06 2016-10-06 COMPOSITIONS AND METHODS COMPRISING THE USE OF EXIGUOBACTERIUM ACETYLICUM AND BACILLUS COAGLUANS α-GLUCANOTRANSFERASE ENZYMES

Publications (1)

Publication Number Publication Date
BR112018006787A2 true BR112018006787A2 (pt) 2018-10-23

Family

ID=57200110

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018006787A BR112018006787A2 (pt) 2015-10-06 2016-10-06 composições e métodos que compreendem o uso de enzimas alfa-glucanotransferase de exiguobacterium acetylicum e bacillus coagluans

Country Status (8)

Country Link
US (2) US11072783B2 (pt)
EP (1) EP3359656B1 (pt)
CN (1) CN108368492B (pt)
AU (1) AU2016336555A1 (pt)
BR (1) BR112018006787A2 (pt)
DK (1) DK3359656T3 (pt)
MX (1) MX2018004188A (pt)
WO (1) WO2017062687A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3827090A1 (en) 2018-07-23 2021-06-02 Danisco US Inc. Alpha-glucose-1 -phosphate synthesis from sucrose and glucan synthesis using glucan phosphorylases
WO2022169357A1 (en) * 2021-02-02 2022-08-11 Coöperatie Koninklijke Avebe U.A. Novel anti-staling enzyme, and methods, doughs and baked food products relating thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617143B1 (en) * 1999-10-20 2003-09-09 Novozymes A/S Polypeptides having glucanotransferase activity and nucleic acids encoding same
CA2713582C (en) 2008-02-04 2017-02-21 Danisco Us Inc. Ts23 alpha-amylase variants with altered properties
EP2248907A1 (en) * 2009-05-08 2010-11-10 Rijksuniversiteit Groningen Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them

Also Published As

Publication number Publication date
EP3359656A1 (en) 2018-08-15
DK3359656T3 (da) 2021-01-18
AU2016336555A1 (en) 2018-04-12
MX2018004188A (es) 2018-05-17
CN108368492A (zh) 2018-08-03
US20220090030A1 (en) 2022-03-24
WO2017062687A1 (en) 2017-04-13
US11884942B2 (en) 2024-01-30
US20180265852A1 (en) 2018-09-20
CN108368492B (zh) 2022-01-28
EP3359656B1 (en) 2020-12-16
US11072783B2 (en) 2021-07-27

Similar Documents

Publication Publication Date Title
WO2019126634A3 (en) Targeted integration of nucleic acids
BR112017023975A2 (pt) variantes de alfa-amilase e polinucleotídeos codificando as mesmas
PH12016501671B1 (en) Novel polysaccharide and uses thereof
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
BR112017015567A2 (pt) proteína gl de citomegalovírus recombinante ou fragmento de formação de complexo da mesma, complexo de citomegalovírus, ácido nucleico isolado, célula hospedeira, e, composição imunogênica
BR112018008766A2 (pt) variantes, composições e métodos e utilizações do fator viii reduzido cpg para o tratamento de transtornos hemostásicos
BR112017008976A2 (pt) ?composição, métodos de aumento da viscosidade de composições aquosas, de tratamento de material, de produção de dextrano e reação enzimática?
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
BR112018011073A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes e métodos de utilização
BR112017006736A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
EP4257152A3 (en) Apelin polypeptides
BR112021022666A2 (pt) Frações de separação e seus métodos e uso
BR112017014060A2 (pt) composições de bacillus licheniformis rti184 e métodos de uso para beneficiar o crescimento de plantas
BR112019024813A2 (pt) adenovírus recombinantes portando transgenes
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
BR112018072530A2 (pt) variantes de protease e usos das mesmas
MX2018007325A (es) Promotor de catalasa modificado bidireccional de bacilo.
BR112016023688A2 (pt) célula hospedeira, métodos para produzir um bioconjugado, para tratar ou prevenir uma infecção por pseudomonas em um indivíduo e para induzir uma resposta imune contra pseudomonas em um indivíduo, bioconjugado, composição, uso de um bioconjugado ou uma composição, e, sequência de ácido nucleico isolada
MX2019009229A (es) Novedosas variantes enzimaticas que degradan la nicotina.
BR112017002741A2 (pt) peptídeos contendo manose-6-fosfato fundidos a enzimas lisossômicas
CL2018001279A1 (es) Spodoptera frugiperda resistente a vip3a.
CL2019003248A1 (es) Disminución de homocisteína mediada por enzimas humanas para el tratamiento de pacientes con hiperhomocisteinemia y homocistinuria.
BR112016013800A2 (pt) Composições e métodos para reduzir alérgenos de gatos no ambiente
BR112018006787A2 (pt) composições e métodos que compreendem o uso de enzimas alfa-glucanotransferase de exiguobacterium acetylicum e bacillus coagluans
EP3612199A4 (en) COMMENSAL BACTERIA AS A NEW TREATMENT FOR DRY EYE AND SJÖGREN'S SYNDROME

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2691 DE 02-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.